Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum [Yahoo! Finance]
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: Yahoo! Finance
Stock move and recent performance snapshot Tango Therapeutics (TNGX) has drawn attention after a recent 3% daily decline, following a relatively flat week but a strong month and past 3 months, putting its recent share performance on many investors' radar. See our latest analysis for Tango Therapeutics. At a share price of US$19.26, Tango's recent 1 month and year to date share price returns above 70% and 100% respectively contrast with an already very large 1 year total shareholder return, which may indicate that momentum has been building. If you are curious about other fast moving health related names, this could be a good moment to scan for promising healthcare AI opportunities using the 34 healthcare AI stocks With Tango trading around US$19.26 and only a small gap to an average analyst price target near US$20.44, the key question now is whether recent gains leave limited upside or if the market is still underestimating future growth. Preferred Price-to-Sales of 44.1x
Show less
Read more
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Is Tango Therapeutics (TNGX) Building the Right Leadership Mix to Navigate Complex Oncology Pipelines? [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of VopimetostatGlobeNewswire
- Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..MarketBeat
- Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics (TNGX) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.MarketBeat
TNGX
Earnings
- 3/5/26 - Beat
TNGX
Sec Filings
- 4/17/26 - Form ARS
- 4/17/26 - Form DEFA14A
- 4/17/26 - Form DEF
- TNGX's page on the SEC website